Abstract:Folate-targeted poly[(p-nitrophenyl acrylate)-co-(N-isopropylacrylamide)] nanohydrogel (F-SubMG) was loaded with 5-fluorouracil (5-FU) to obtain low (16.3 ± 1.9 μg 5-FU/mg F-SubMG) and high (46.8 ± 3.8 μg 5-FU/mg F-SubMG) load 5-FU-loaded F-SubMGs. The complete in vitro drug release took place in 8 h. The cytotoxicity of unloaded F-SubMGs in MCF7 and HeLa cells was low; although it increased for high F-SubMG concentration. The administration of 10 μM 5-FU by 5-FU-loaded F-SubMGs was effective on both cellular … Show more
“…441,442 The activated ester site allowed covalent conjugation of pyridine and folic-acid-functionalized amines for anticancer drug delivery. 443 In the recent past, reactive surface-immobilized hydrogels have attracted significant interest as biomimetic matrices to study the influence of different physiological signals (both chemical and mechanical) on the cell behavior. 444,445 These artificial matrices frequently rely on hydrogel films; their tunable swelling properties depend upon the extent of crosslinking.…”
“…441,442 The activated ester site allowed covalent conjugation of pyridine and folic-acid-functionalized amines for anticancer drug delivery. 443 In the recent past, reactive surface-immobilized hydrogels have attracted significant interest as biomimetic matrices to study the influence of different physiological signals (both chemical and mechanical) on the cell behavior. 444,445 These artificial matrices frequently rely on hydrogel films; their tunable swelling properties depend upon the extent of crosslinking.…”
“…59 To our knowledge, no chemically modified FA-targeted PEGylated polymeric NCs with a coreÀshell structure has been prepared and tested previously. The closest to our system was described by Rata-Aguilar et al 60 in which FAÀchitosan conjugate was utilized to physically coat the preformed oilÀlecithin NCs with folic acid.…”
In this work we describe the formulation and characterization of chemically modified polymeric nanocapsules incorporating the anticancer drug, quercetin, for the passive and active targeting to tumors. Folic acid was conjugated to poly(lactide-co-glycolide) (PLGA) polymer to facilitate active targeting to cancer cells. Two different methods for the conjugation of PLGA to folic acid were employed utilizing polyethylene glycol (PEG) as a spacer. Characterization of the conjugates was performed using FTIR and (1)H NMR studies. The PEG and folic acid content was independent of the conjugation methodology employed. PEGylation has shown to reduce the size of the nanocapsule; moreover, zeta-potential was shown to be polymer-type dependent. Comparative studies on the cytotoxicity and cellular uptake of the different formulations by HeLa cells, in the presence and absence of excess folic acid, were carried out using MTT assay and Confocal Laser Scanning Microscopy, respectively. Both results confirmed the selective uptake and cytotoxicity of the folic acid targeted nanocapsules to the folate enriched cancer cells in a folate-dependent manner. Finally, the passive tumor accumulation and the active targeting of the nanocapsules to folate-expressing cells were confirmed upon intravenous administration in HeLa or IGROV-1 tumor-bearing mice. The developed nanocapsules provide a system for targeted delivery of a range of hydrophobic anticancer drugs in vivo.
“…As the HeLa cells are folate receptor-positive, the cellular uptake efficiency of F-SubMGs was higher in HeLa cells than MCF7 cells. These results demonstrate that the mean residence time of the drug was increased to 60 days and, therefore, the folate-conjugate submicrogels have great efficiency in controlling the release of 5-FU, which may lead to an innovative choice for treating numerous malignancies 54 .…”
Nanotechnology offers a number of nanoscale implements for medicine. Among these, nanoparticles are revolutionizing the field of drug and gene delivery. Chitosan is a natural polymer which provides a profitable tool to an innovative delivery system due to its inherent physicochemical and biological characteristics. Chitosan nanoparticles are promising drug and gene delivery carriers because of small size, better stability, low toxicity, inexpensiveness, simplicity, easy fabrication and versatile means of administration. Chitosan can also be easily modified chemically due to the presence of reactive functional hydroxide and amine groups. Folic acid is commonly engaged as a ligand, for targeting cancer cells, as its receptor, that transports folic acid into the cells through endocytosis and is over-expressed on the surface of several human epithelial cancer cells. Integrating folic acid into chitosan-based drug delivery inventions directs the systems with a well-organized targeting ability. The present review outlines several illustrations of this versatile system based on folate decorated chitosan, which have shown potential as auspicious delivery systems published over the past few years. In addition, it is probable to formulate chitosan nanocarriers that exhibit manifold usage beyond targeted delivery, such as nanotheranostics and cancer stem cell therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.